Vanguard Group’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Sell |
1,107,491
-7,933
| -0.7% | -$90.2K | ﹤0.01% | 2786 |
|
|
2025
Q1 | $11.2M | Buy |
1,115,424
+559,951
| +101% | +$5.62M | ﹤0.01% | 2783 |
|
|
2024
Q4 | $9.85M | Buy |
555,473
+48,706
| +10% | +$864K | ﹤0.01% | 2969 |
|
|
2024
Q3 | $10.4M | Buy |
506,767
+436,767
| +624% | +$8.94M | ﹤0.01% | 2940 |
|
|
2024
Q2 | $1.63M | Buy |
+70,000
| New | +$1.63M | ﹤0.01% | 3628 |
|